How Are Pregnant Patients With Irritable Bowel Syndrome or Functional Dyspepsia Managed Pharmacologically? A Cross‐Sectional Study Using a Global Database

Key Points

• This research aims to analyze pharmacological management practices for irritable bowel syndrome and functional dyspepsia during pregnancy.
• Utilized a global database to identify pregnant patients with IBS or FD
• Analyzed prescriptions, focusing on CLASSC medications
• Cross-sectional analysis of treatment characteristics
• High prevalence of CLASSC prescriptions observed among pregnant patients
• Identified notable characteristics of patients receiving these prescriptions
• Highlights a significant gap in research regarding safe treatment during pregnancy